Thomas Patrick Kelly - 16 Jun 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
Chief Financial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jun 2023
Net transactions value
-$23,835
Form type
4
Filing time
21 Jun 2023, 16:05:23 UTC
Previous filing
17 Feb 2023
Next filing
31 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $23,835 -1,655 -2.8% $14.40 57,140 16 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.